全文获取类型
收费全文 | 2452篇 |
免费 | 119篇 |
国内免费 | 31篇 |
专业分类
耳鼻咽喉 | 17篇 |
儿科学 | 86篇 |
妇产科学 | 83篇 |
基础医学 | 271篇 |
口腔科学 | 55篇 |
临床医学 | 184篇 |
内科学 | 625篇 |
皮肤病学 | 33篇 |
神经病学 | 200篇 |
特种医学 | 64篇 |
外科学 | 419篇 |
综合类 | 3篇 |
预防医学 | 139篇 |
眼科学 | 45篇 |
药学 | 168篇 |
中国医学 | 1篇 |
肿瘤学 | 209篇 |
出版年
2024年 | 3篇 |
2023年 | 27篇 |
2022年 | 47篇 |
2021年 | 83篇 |
2020年 | 52篇 |
2019年 | 83篇 |
2018年 | 96篇 |
2017年 | 52篇 |
2016年 | 57篇 |
2015年 | 83篇 |
2014年 | 120篇 |
2013年 | 118篇 |
2012年 | 182篇 |
2011年 | 206篇 |
2010年 | 86篇 |
2009年 | 96篇 |
2008年 | 160篇 |
2007年 | 164篇 |
2006年 | 129篇 |
2005年 | 121篇 |
2004年 | 120篇 |
2003年 | 107篇 |
2002年 | 84篇 |
2001年 | 39篇 |
2000年 | 27篇 |
1999年 | 27篇 |
1998年 | 14篇 |
1997年 | 20篇 |
1996年 | 16篇 |
1995年 | 13篇 |
1994年 | 16篇 |
1993年 | 4篇 |
1992年 | 22篇 |
1991年 | 12篇 |
1990年 | 15篇 |
1989年 | 18篇 |
1988年 | 9篇 |
1987年 | 9篇 |
1986年 | 7篇 |
1985年 | 10篇 |
1984年 | 5篇 |
1983年 | 4篇 |
1982年 | 4篇 |
1981年 | 3篇 |
1980年 | 3篇 |
1979年 | 5篇 |
1978年 | 6篇 |
1974年 | 3篇 |
1973年 | 3篇 |
1970年 | 2篇 |
排序方式: 共有2602条查询结果,搜索用时 15 毫秒
21.
The effect of antibiotic resistance on the outcome of three 1-week triple therapies against Helicobacter pylori 总被引:9,自引:0,他引:9
Pilotto A Leandro G Franceschi M Rassu M Bozzola L Furlan F Di Mario F Valerio G 《Alimentary pharmacology & therapeutics》1999,13(5):667-673
BACKGROUND: Resistance of Helicobacter pylori to antibiotics may be a major reason for treatment failure. AIM: To evaluate the effect of primary H. pylori resistance to antibiotics on the cure rates of three anti-H. pylori 1-week triple therapies. METHODS: One hundred and sixteen consecutive patients diagnosed H. pylori-positive by gastric histology, rapid urease test and culture were enrolled. Activity of tested antibiotics was determined by means of the E-test. Patients were treated for 7 days with: (i) pantoprazole 40 mg o.d. plus amoxycillin 1 g b.d. and metronidazole 250 mg q.d.s. (PAM); (ii) pantoprazole 40 mg o.d. plus clarithromycin 250 mg b.d. and metronidazole 250 mg q.d.s. (PCM); or (iii) pantoprazole 40 mg o.d. plus amoxycillin 1 g b.d. and clarithromycin 250 mg b.d. (PAC). Two months after completion of therapy, endoscopy and gastric biopsies were repeated. RESULTS: Primary resistance rates to metronidazole, clarithromycin and amoxycillin were 17.2, 6.9 and 0%, respectively. Overall H. pylori cure rates expressed as intention-to-treat and per protocol analyses were, respectively, 79% and 86% with PAM, 82% and 89% with PCM, and 85% and 85% with PAC. Significantly lower cure rates were observed in metronidazole-resistant patients treated with PAM (56% vs. 96%, P = 0.01) or PCM (50% vs. 97%, P = 0.01). A trend towards lower H. pylori cure rates was observed in clarithromycin-resistant patients treated with PCM (67% vs. 91%, P = 0.74) or PAC (50% vs. 87%, P = 0.68). CONCLUSION: Primary resistance to metronidazole influences the H. pylori cure rate of anti-H. pylori proton pump inhibitor-based triple therapies which include this antibiotic. A similar trend exists for primary clarithromycin resistance. 相似文献
22.
23.
Subsequent to a peripheral nerve injury, there are changes in gene expression within the dorsal root ganglia in response to the damage. This review selects factors which are well-known to be vital for inflammation, cell death and nociception, and highlights how alterations in their gene expression within the dorsal root ganglia can affect functional recovery. The majority of studies used polymerase chain reaction within animal models to analyse the dynamic changes following peripheral nerve injuries. This review aims to highlight the factors at the gene expression level that impede functional recovery and are hence are potential targets for therapeutic approaches. Where possible the experimental model, specific time-points and cellular location of expression levels are reported. 相似文献
24.
25.
26.
Risk of Active Tuberculosis among Index Case of Householders—A Long‐Term Assessment after the Conventional Contacts Study
下载免费PDF全文
![点击此处可从《Public health nursing (Boston, Mass.)》网站下载免费的PDF全文](/ch/ext_images/free.gif)
27.
28.
Daniele De Meo Benedetta Zucchi Valerio Castagna Edoardo M. Pieracci Massimiliano Mangone Alessandro Calistri 《Current medical research and opinion》2020,36(8):1375-1381
AbstractObjective: The Unified Classification System (UCS) presents itself as an evolution of the Vancouver Classification (VCS) for the evaluation of periprosthetic fractures of the proximal femur (PPF). The aim of our study was to highlight any loss of reproducibility or validity of the new classification system, compared to the previous one.Material and methods: We tested the interobserver and intraobserver agreement using 40 PPF clinical cases. Each classifying subtype of the UCS and VCS was present in at least two cases. Six experienced hip surgeons (Senior Surgeon, SS) and 5 surgeons in training (Junior Surgeon, JS) classified the clinical cases, using VCS and UCS. The validity of both classifications was then tested with intraoperative surveys.Results: The mean κ value for interobserver agreement for the VCS in the JS group was 0.65 and 0.81 for the SS group. The mean κ value for interobserver agreement for the UCS in the JS group was 0.63 and 0.65 for the SS group. The mean κ value for intraobserver agreement for the VCS in the JS group was 0.71 and 0.73 for the SS group. The mean κ value for intraobserver agreement for the UCS in the JS group was 0.72 and 0.7 for the SS group. Validity analysis showed a moderate agreement for the VCS and a good agreement for the UCS.Conclusion: The UCS completes the Vancouver classification, expanding it. It is reliable, despite the increase in classification categories and number of parameters to evaluate, with a slightly higher validity. 相似文献
29.
30.